logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Dr. Lal Path Labs Appoints Shankha Banerjee As CEO

Mar 17, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Dr. Lal PathLabs Limited

Shankha Banerjee
IndiaHealth DiagnosticsMedicalBiotechnologyHealth Care

Description

Dr. Lal PathLabs Limited announced the appointment of Shankha Banerjee as its new Chief Executive Officer (CEO) and Key Managerial Personnel, effective from May 21, 2024.

Company Information

Company

Dr. Lal PathLabs Limited

Location

India

About

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. The company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. As of 31 March 2023, the company has 277 clinical laboratories, 5,102 patient service centers (PSCs) and 10,938 pick-up points (PUPs).

Company News

(10 articles)
Mon, 02 Jun 2025 07:00:00 GMT

Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - simplywall.st

Sat, 21 Jun 2025 07:00:00 GMT

Delhi consumer panel upholds verdict indicting Dr Lal Pathlabs for wrong report - ET HealthWorld

Mon, 28 Apr 2025 07:00:00 GMT

Dr. Lal Path Labs posts Q4 FY25 consolidated PAT at Rs. 154.8 Cr - Indian Pharma Post

Mon, 30 Jun 2025 07:00:00 GMT

Delhi State Commission Rules Dr Lal Path Labs Liable for Inaccurate Test Reports, Upholds Rs. 3.5 Lakh Compensation - Legal Maestros

Tue, 13 Aug 2024 07:00:00 GMT

Dr. Lal Pathlabs redesignates Ved Prakash as Group CFO and CEO – International Business - financialexpress.com

Fri, 09 Oct 2020 07:00:00 GMT

Dr Lal PathLabs leaks millions of patients data in public domain: Report - The Indian Express

Fri, 10 May 2024 07:00:00 GMT

Lal PathLabs Q4 Results: Net profit rises 49%, announces dividend of ₹6 per share - CNBC TV18

Thu, 08 Aug 2024 07:00:00 GMT

Dr Lal Pathlabs drops 4% as valuation concerns outweigh Q1FY25 positives - Moneycontrol

Wed, 09 Feb 2022 08:00:00 GMT

Dr. Lal PathLabs spends its CSR budget on healthcare and skill development - TheCSRUniverse

Sun, 11 Oct 2020 07:00:00 GMT

Cyber experts demand heavy penalties against Dr Lal Pathlabs for not securing sensitive data - The420.in

FundzWatch™ Score

60
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months